Relating to gender disparities in cost of pharmaceuticals; and prescribing an effective date.

Requires Department of Consumer and Business Services to study cost differences in hormone replacement drugs used by men and hormone replacement drugs used by women and report findings to Legislative Assembly no later than September 15, 2022. Requires department to keep strictly confidential information submitted in accordance with prescription drug price transparency program that is collected, used or relied upon for study, if information is not already in public domain and is confidential, proprietary or trade secret. Sunsets January 2, 2023. Takes effect on 91st day following adjournment sine die.